Dr. Stieglitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
HDFCCC Stieglitz Lab
1450 3rd St, Room 283
San Francisco, CA 94158Phone+1 415-476-3831- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2008 - 2011
- Stony Brook University Health Sciences Center School of MedicineClass of 2008
Certifications & Licensure
- CA State Medical License 2011 - 2024
- NY State Medical License 2009 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- K08 Clinical Investigator Award NHLBI @ NIH, 2017
- Individual Investigator Award American Cancer Society, 2016
- Rally Grant Rally Foundation for Childhood Cancer Research, 2016
- Join now to see all
Clinical Trials
- Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML Start of enrollment: 2014 Mar 01
- Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia Start of enrollment: 2018 Sep 09
- Expanded Access Program for SNDX-5613
Roles: Contact
Publications & Presentations
PubMed
- Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik Kang, Nikhil Chilakapati, Naomi Akagi, Haley Johnson, Tasfia Rashid, Juwita Werner, Abhilash Barpanda, Huim...> ;Biorxiv. 2024 Feb 28
- 1 citationsDesensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization.Feldman, K., Aaronson, K., Gu, T., Ige, K., Southworth, E., Sanchez, L., Stieglitz, E.> ;Pediatric Blood & Cancer. 2024 Apr 1
- Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemi...Verma, A., Chi, Y., Malvar, J., Lamble, A., Chaudhury, S., Agarwal, A., Li, H., Liang, G., Leong, R., Brown, P., Kaplan, J., Schafer, E., Slone, T., Pauly, M., Chang, ...> ;Cancers. 2024 Jan 24
- Join now to see all
Journal Articles
- Downregulating Notch Counteracts KrasG12D-Induced ERK Activation and Oxidative Phosphorylation in Myeloproliferative NeoplasmErik A Ranheim, David Yang, Warren S Pear, Lan Zhou, Mignon Loh, Eric Padron, Elliot Stieglitz, Nature
Abstracts/Posters
- In Vitro-Selected Nanobody-Based Cellular Therapy Targeting CD72 for Treatment of Refractory B-Cell MalignanciesElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- DNA Methylation As a Biomarker of Outcome in JMML: An International Effort Towards Clinical ImplementationElliot Stieglitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Promising New Combination of Drugs Identified to Treat Juvenile Myelomonocytic LeukemiaApril 7th, 2023
- Baby Diagnosed with Rare Blood Cancer Saved by Miracle TreatmentSeptember 26th, 2019
- Liver Cancer Drug for Adults Saves the Life of an Infant with Deadly LeukemiaSeptember 12th, 2019
- Join now to see all
Other Languages
- Spanish
Hospital Affiliations
- UCSF Benioff Childrens HospitalSan Francisco, California
- UCSF Medical CenterSan Francisco, California
External Links
- LinkedInhttp://www.linkedin.com/pub/elliot-stieglitz/20/384/870
- Stieglitz Labhttps://www.stieglitzlab.com
- ElliotStieglitz.comhttp://www.elliotstieglitz.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: